Spain Pharmaceuticals & Healthcare Q3 2018
The Spanish government will remain committed fiscal consolidation, targeting the healthcare sector and prescriptiondrug expenditure in particular, as it faces considerable pressure from rising healthcare costs. Spain’s out-of-pocket expenditure onhealth is well above the EU average, a result of health reforms which shifted some of the costs for healthcare and medicine ontohouseholds. These trends, combined with the forecasted economic slowdown in the coming years, will limit revenue earningopportunities for multinational drugmakers operating in the country.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook